Ngā hua rapu kaituhi :: APM

1

Laboratory Identification of Clinically Important Aerobic Actinomycetes mā David Berd

I whakaputaina 1973

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Laboratory Identification of Clinically Important Aerobic Actinomycetes mā David Berd

I whakaputaina 1973

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Immunopharmacologic Analysis of an Autologous, Hapten-Modified Human Melanoma Vaccine mā David Berd, Takami Sato, Henry Maguire, John C. Kairys, Michael J. Mastrangelo

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy mā David Berd, John L. Cornog, Ronald C. DeConti, Martin Levitt, Joseph R. Bertino

I whakaputaina 1975

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma mā Edward F. McClay, Michael J. Mastrangelo, John D. Sprandio, Robert E. Bellet, David Berd

I whakaputaina 1989

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Protracted survival after resection of metastatic uveal melanoma mā Takekazu Aoyama, Michael J. Mastrangelo, David Berd, Faith E. Nathan, Carol L. Shields, Jerry A. Shields, Ernest L. Rosato, Francis E. Rosato, Takami Sato

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Deletion mapping of chromosome region 9p21-p22 surrounding theCDKN2 locus in melanoma mā Masataka Ohta, David Berd, Masayoshi Shimizu, Hirokazu Nagai, Maria‐Grazia Cotticelli, Michael J. Mastrangelo, Jerry A. Shields, Carol L. Shields, Carlo M. Croce, Kay Huebner

I whakaputaina 1996

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

High-Dose Immunoembolization: Survival Benefit in Patients with Hepatic Metastases from Uveal Melanoma mā Akira Yamamoto, Inna Chervoneva, Kevin L. Sullivan, David J. Eschelman, Carin F. Gonsalves, Michael J. Mastrangelo, David Berd, Jerry A. Shields, Carol L. Shields, Mizue Terai, Takami Sato

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor mā Takami Sato, David J. Eschelman, Carin F. Gonsalves, Mizue Terai, Inna Chervoneva, Peter A. McCue, Jerry A. Shields, Carol L. Shields, Akira Yamamoto, David Berd, Michael J. Mastrangelo, Kevin L. Sullivan

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte–Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases mā Matías E. Valsecchi, Mizue Terai, David J. Eschelman, Carin F. Gonsalves, Inna Chervoneva, Jerry A. Shields, Carol L. Shields, Akira Yamamoto, Kevin L. Sullivan, M. Laudadio, David Berd, Michael J. Mastrangelo, Takami Sato

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: